Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression
Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity re...
Gespeichert in:
Veröffentlicht in: | Journal of neuroscience research 1999-11, Vol.58 (4), p.593-598 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 598 |
---|---|
container_issue | 4 |
container_start_page | 593 |
container_title | Journal of neuroscience research |
container_volume | 58 |
creator | Serou, Michael J. DeCoster, Mark A. Bazan, Nicolas G. |
description | Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1097-4547(19991115)58:4<593::AID-JNR12>3.0.CO;2-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69215759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69215759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4722-4d689f7c6f0b2afe1c02e3784b1ccbfed3d7f8fc01cfa911075b2eb24e4b0b373</originalsourceid><addsrcrecordid>eNqFkd9u0zAUxiMEYqXwCshXaLtI8Z-4acoEmgqMbqOdYGjcHTnOyWaWOsFOoH1Y3gWXlIHEJK585PP5-47PL4peMTpilPLn-x_ns_kBo1kaJzJJ91mWZYwxeSAn0-RQZmI6PZq_jk8WHxh_KUZ0NFu-4HFyLxrcvrkfDagY0zihjO9Fj7z_QinNMikeRnuMSiGoZIPox9y26CrsboyNGcmxVUTp1nxTLXqC68ah96a2pC6J3uiqrtebK7TKY8yJsgUxtui0ySsk1rTOaFKvTYHEb2x7HVShTxpnVsptyLVpmlqrVaMqYrFztQ2F7qq2czgl51WIrLCNd_HGXpEy1LUjyhMVXLBEh7Y14dUKC6O2rbvG-jP14-hBqSqPT3bnMPr09s3F7F18tjyez47OYp2kPOytGE-yMtXjkuZclcg05SjSSZIzrfMSC1Gk5aTUlOlSBQ40lTnHnCeY5DQXqRhGz3rfxtVfO_QtrIzXWFXKYt15GGecyTRgG0aXvVC72vvwI9gtBxiFLXmALXnYUoQtRfhNHuQEEggWAIE8_CIPAijMlsAhCc5PdyN0edjOX7496iD43Au-mwo3_-T-N_au1P4iWMe9tfEtrm-tlbuBcSpSCZeLY3h_enpxvpAncCZ-AvYj4QY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69215759</pqid></control><display><type>article</type><title>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Serou, Michael J. ; DeCoster, Mark A. ; Bazan, Nicolas G.</creator><creatorcontrib>Serou, Michael J. ; DeCoster, Mark A. ; Bazan, Nicolas G.</creatorcontrib><description>Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/(SICI)1097-4547(19991115)58:4<593::AID-JNR12>3.0.CO;2-4</identifier><identifier>PMID: 10533051</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Animals ; Azepines - pharmacology ; BN50730 ; COX-2 ; Cyclooxygenase 2 ; Enzyme Induction - drug effects ; Enzyme Induction - physiology ; Hippocampus - cytology ; Hippocampus - drug effects ; Hippocampus - enzymology ; IL-1β ; Interleukin-1 - physiology ; Isoenzymes - biosynthesis ; Mice ; neurons ; Neurons - drug effects ; Neurons - enzymology ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type II ; PAF ; Platelet Activating Factor - analogs & derivatives ; Platelet Activating Factor - pharmacology ; Platelet Aggregation Inhibitors - pharmacology ; Prostaglandin-Endoperoxide Synthases - biosynthesis ; Rats ; Recombinant Proteins - pharmacology ; seizures ; Thienopyridines ; Triazoles - pharmacology</subject><ispartof>Journal of neuroscience research, 1999-11, Vol.58 (4), p.593-598</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>Copyright 1999 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4722-4d689f7c6f0b2afe1c02e3784b1ccbfed3d7f8fc01cfa911075b2eb24e4b0b373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-4547%2819991115%2958%3A4%3C593%3A%3AAID-JNR12%3E3.0.CO%3B2-4$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-4547%2819991115%2958%3A4%3C593%3A%3AAID-JNR12%3E3.0.CO%3B2-4$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10533051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Serou, Michael J.</creatorcontrib><creatorcontrib>DeCoster, Mark A.</creatorcontrib><creatorcontrib>Bazan, Nicolas G.</creatorcontrib><title>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Azepines - pharmacology</subject><subject>BN50730</subject><subject>COX-2</subject><subject>Cyclooxygenase 2</subject><subject>Enzyme Induction - drug effects</subject><subject>Enzyme Induction - physiology</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - enzymology</subject><subject>IL-1β</subject><subject>Interleukin-1 - physiology</subject><subject>Isoenzymes - biosynthesis</subject><subject>Mice</subject><subject>neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - enzymology</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type II</subject><subject>PAF</subject><subject>Platelet Activating Factor - analogs & derivatives</subject><subject>Platelet Activating Factor - pharmacology</subject><subject>Platelet Aggregation Inhibitors - pharmacology</subject><subject>Prostaglandin-Endoperoxide Synthases - biosynthesis</subject><subject>Rats</subject><subject>Recombinant Proteins - pharmacology</subject><subject>seizures</subject><subject>Thienopyridines</subject><subject>Triazoles - pharmacology</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd9u0zAUxiMEYqXwCshXaLtI8Z-4acoEmgqMbqOdYGjcHTnOyWaWOsFOoH1Y3gWXlIHEJK585PP5-47PL4peMTpilPLn-x_ns_kBo1kaJzJJ91mWZYwxeSAn0-RQZmI6PZq_jk8WHxh_KUZ0NFu-4HFyLxrcvrkfDagY0zihjO9Fj7z_QinNMikeRnuMSiGoZIPox9y26CrsboyNGcmxVUTp1nxTLXqC68ah96a2pC6J3uiqrtebK7TKY8yJsgUxtui0ySsk1rTOaFKvTYHEb2x7HVShTxpnVsptyLVpmlqrVaMqYrFztQ2F7qq2czgl51WIrLCNd_HGXpEy1LUjyhMVXLBEh7Y14dUKC6O2rbvG-jP14-hBqSqPT3bnMPr09s3F7F18tjyez47OYp2kPOytGE-yMtXjkuZclcg05SjSSZIzrfMSC1Gk5aTUlOlSBQ40lTnHnCeY5DQXqRhGz3rfxtVfO_QtrIzXWFXKYt15GGecyTRgG0aXvVC72vvwI9gtBxiFLXmALXnYUoQtRfhNHuQEEggWAIE8_CIPAijMlsAhCc5PdyN0edjOX7496iD43Au-mwo3_-T-N_au1P4iWMe9tfEtrm-tlbuBcSpSCZeLY3h_enpxvpAncCZ-AvYj4QY</recordid><startdate>19991115</startdate><enddate>19991115</enddate><creator>Serou, Michael J.</creator><creator>DeCoster, Mark A.</creator><creator>Bazan, Nicolas G.</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991115</creationdate><title>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</title><author>Serou, Michael J. ; DeCoster, Mark A. ; Bazan, Nicolas G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4722-4d689f7c6f0b2afe1c02e3784b1ccbfed3d7f8fc01cfa911075b2eb24e4b0b373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Azepines - pharmacology</topic><topic>BN50730</topic><topic>COX-2</topic><topic>Cyclooxygenase 2</topic><topic>Enzyme Induction - drug effects</topic><topic>Enzyme Induction - physiology</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - enzymology</topic><topic>IL-1β</topic><topic>Interleukin-1 - physiology</topic><topic>Isoenzymes - biosynthesis</topic><topic>Mice</topic><topic>neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - enzymology</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type II</topic><topic>PAF</topic><topic>Platelet Activating Factor - analogs & derivatives</topic><topic>Platelet Activating Factor - pharmacology</topic><topic>Platelet Aggregation Inhibitors - pharmacology</topic><topic>Prostaglandin-Endoperoxide Synthases - biosynthesis</topic><topic>Rats</topic><topic>Recombinant Proteins - pharmacology</topic><topic>seizures</topic><topic>Thienopyridines</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serou, Michael J.</creatorcontrib><creatorcontrib>DeCoster, Mark A.</creatorcontrib><creatorcontrib>Bazan, Nicolas G.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serou, Michael J.</au><au>DeCoster, Mark A.</au><au>Bazan, Nicolas G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>1999-11-15</date><risdate>1999</risdate><volume>58</volume><issue>4</issue><spage>593</spage><epage>598</epage><pages>593-598</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>10533051</pmid><doi>10.1002/(SICI)1097-4547(19991115)58:4<593::AID-JNR12>3.0.CO;2-4</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-4012 |
ispartof | Journal of neuroscience research, 1999-11, Vol.58 (4), p.593-598 |
issn | 0360-4012 1097-4547 |
language | eng |
recordid | cdi_proquest_miscellaneous_69215759 |
source | MEDLINE; Wiley Online Library Journals |
subjects | Animals Azepines - pharmacology BN50730 COX-2 Cyclooxygenase 2 Enzyme Induction - drug effects Enzyme Induction - physiology Hippocampus - cytology Hippocampus - drug effects Hippocampus - enzymology IL-1β Interleukin-1 - physiology Isoenzymes - biosynthesis Mice neurons Neurons - drug effects Neurons - enzymology Nitric Oxide Synthase - metabolism Nitric Oxide Synthase Type II PAF Platelet Activating Factor - analogs & derivatives Platelet Activating Factor - pharmacology Platelet Aggregation Inhibitors - pharmacology Prostaglandin-Endoperoxide Synthases - biosynthesis Rats Recombinant Proteins - pharmacology seizures Thienopyridines Triazoles - pharmacology |
title | Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T17%3A49%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-1%20beta%20activates%20expression%20of%20cyclooxygenase-2%20and%20inducible%20nitric%20oxide%20synthase%20in%20primary%20hippocampal%20neuronal%20culture:%20Platelet-activating%20factor%20as%20a%20preferential%20mediator%20of%20cyclooxygenase-2%20expression&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Serou,%20Michael%20J.&rft.date=1999-11-15&rft.volume=58&rft.issue=4&rft.spage=593&rft.epage=598&rft.pages=593-598&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/(SICI)1097-4547(19991115)58:4%3C593::AID-JNR12%3E3.0.CO;2-4&rft_dat=%3Cproquest_cross%3E69215759%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69215759&rft_id=info:pmid/10533051&rfr_iscdi=true |